Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 27, 2022

Alvogen Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ALVOGEN, and what generic and branded alternatives to ALVOGEN drugs are available?

ALVOGEN has fifty-eight approved drugs.

Summary for Alvogen

US Patents:	0
Tradenames:	48
Ingredients:	46
NDAs:	58
Patent Litigation for Alvogen:	See patent lawsuits for Alvogen
PTAB Cases with Alvogen as petitioner:	See PTAB cases with Alvogen as petitioner

Drugs and US Patents for Alvogen

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alvogen	BUPRENORPHINE HYDROCHLORIDE	buprenorphine hydrochloride	FILM;BUCCAL	211594-007	Aug 3, 2021		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Alvogen	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	207388-003	Jul 28, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Alvogen	ACETYLCYSTEINE	acetylcysteine	SOLUTION;INHALATION, ORAL	204674-001	Feb 11, 2014	AN	RX	No	No		See Plans and Pricing				See Plans and Pricing
Alvogen	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	202677-002	Jul 26, 2012	AA	RX	No	No		See Plans and Pricing				See Plans and Pricing
Alvogen	BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE	buprenorphine hydrochloride; naloxone hydrochloride	FILM;BUCCAL, SUBLINGUAL	205954-001	Jan 24, 2019	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Alvogen	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	acetaminophen; butalbital; caffeine	TABLET;ORAL	204984-001	Jan 10, 2017	AA	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Alvogen

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alvogen	TRANDATE	labetalol hydrochloride	TABLET;ORAL	018716-002	Aug 1, 1984	4,066,755	See Plans and Pricing
Alvogen	LIDEX	fluocinonide	OINTMENT;TOPICAL	016909-002	Approved Prior to Jan 1, 1982	4,017,615	See Plans and Pricing
Alvogen	SPECTAZOLE	econazole nitrate	CREAM;TOPICAL	018751-001	Dec 23, 1982	3,717,655	See Plans and Pricing
Alvogen	LIDEX	fluocinonide	CREAM;TOPICAL	016908-002	Approved Prior to Jan 1, 1982	3,592,930	See Plans and Pricing
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-002	Oct 31, 1985	3,900,481	See Plans and Pricing
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-003	Jun 3, 1988	4,642,384	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Mallinckrodt

Boehringer Ingelheim

Moodys

Baxter

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.